Should I open or buy a My Eyelab franchise in 2027?

Everyone Says "Optical Franchises Are Safe Bets" — Here's the Truth
I've spent 25 years in revenue leadership, and I've watched more franchise buyers get their wallets picked clean by "safe" concepts than I care to count. So when someone asks me about My Eyelab in 2027, I don't give them the glossy brochure. I give them the truth — with teeth.
Claim #1: "Telehealth exams are a magic bullet for lower costs."
Defense: Everyone loves the idea. No on-site optometrist? No $150K salary burden?
Sounds like free money, right? Here's the reality: telehealth-optometry regulations vary by state — some states outright restrict or prohibit remote exams. My Eyelab's whole value proposition hangs on that remote-doctor technology.
If your state says no, you're suddenly stuck hiring an on-site OD, blowing your cost advantage. I've seen operators buy in, then discover their state's telehealth rules are tighter than a drum. The 2026 FDD lists a franchise fee around $30,000-$50,000 and total Item 7 investment of roughly $400,000 to $700,000 — you're not gambling pocket change here.
The royalty near 6%-8% plus marketing fee near 2%-3% doesn't care about your regulatory surprise.
Claim #2: "Value optical is recession-proof."
Defense: True that vision demand is recession-resilient — people need to see. But "resilient" doesn't mean "profitable without effort." My Eyelab's value-optical positioning targets value-conscious consumers with affordable glasses, contacts, and exams — same-day eyewear.
That's a big market, but it's also the same market Warby Parker, Costco, and Lenscrafters are fighting over. Mature centers gross $800,000-$2,000,000+, with owners clearing $130,000-$400,000. That's solid — but only if you're driving eyewear sales (high-margin) and leveraging the telehealth efficiency where permitted.
The buildout runs $180,000-$380,000, equipment and telehealth tech runs $90,000-$200,000, and initial inventory (eyewear) runs $40,000-$110,000. If you can't move frames, you're just burning capital.

👉 Quick Call with Kory White, Fractional CRO · See Kory on LinkedIn · CRO Syndicate
Claim #3: "The Now Optics group makes it easy."
Defense: Being part of the Now Optics group (sister brand to Stanton Optical) gives you systems and supply chain — that's real. But "easy" is a lie. You're still running a 3,000-4,500 sq ft retail center with an eyewear showroom and telehealth-assisted exam capability.
You need $150,000-$250,000 liquid, full-time operation, and skills in value retail, eyewear sales, and telehealth/regulatory navigation. The winners are operators who leverage the value positioning and telehealth efficiency while navigating regulations. The losers?
Those who can't navigate telehealth-optometry rules, can't compete with value/online eyewear, can't drive eyewear sales, or buy in states restricting telehealth without a plan. I've watched owners who thought "brand solves everything" get eaten alive by staffing — initial marketing runs $25,000-$60,000 just to get customers in the door, and training and travel costs $12,000-$32,000.
If you can't staff opticians, you're dead in the water.
The Real Numbers (I'm Not Making This Up)
| Line Item | Low | High |
|---|---|---|
| Franchise fee | $30,000 | $50,000 |
| Buildout/leasehold | $180,000 | $380,000 |
| Equipment & telehealth | $90,000 | $200,000 |
| Signage & decor | $20,000 | $60,000 |
| Initial inventory (eyewear) | $40,000 | $110,000 |
| Initial marketing | $25,000 | $60,000 |
| Training & travel | $12,000 | $32,000 |
| Working capital | $40,000 | $100,000 |
| Total Item 7 | ~$400,000 | ~$700,000 |
Revenue reality: mature centers gross $800K-$2.0M+ with owners clearing $130K-$400K. My Eyelab's edge is its value-optical positioning, telehealth-enabled exams (remote-doctor technology allowing exams without a full-time on-site OD in some models — where regulations permit), recession-resilient vision demand, the Now Optics group, and high-margin eyewear.
The trade-offs are telehealth/regulatory considerations, optical competition (Warby Parker, Costco, Lenscrafters, online), and staffing.
The 90-Day Decision Tree (Do This or Don't Buy)
- Day 1-20: Read the 2026 FDD, Item 19, and telehealth-optometry regulations for your state — this is non-negotiable diligence.
- Day 21-40: Interview operators; ask about value model, telehealth, regulations, and net profit.
- Day 41-60: Validate a value-conscious market and confirm telehealth permissibility.
- Day 61-100: Build, staff, and set up telehealth/exam capability.
- Day 101-130: Open and drive customer acquisition.
- Leverage the value positioning and telehealth efficiency.
- Drive eyewear sales (high-margin).
Alternative Plays (Because You Have Options)
- Stanton Optical — value optical (Now Optics sister, see fr0966).
- My Eyelab for tech-enabled value optical.
- Pearle Vision — recognized eye care (see fr0964).
- Lenscrafters / optical — eyewear retail (EssilorLuxottica).
- Independent value-optical center — full control, no brand.
- Other optical/healthcare-retail franchises — adjacent models.
The Bottom Line
My Eyelab works — for the right operator in the right state with the right regulatory landscape. It's not a passive check-writer. It's a full-time, retail-and-tech-minded operation where your success hinges on value positioning, telehealth efficiency, and eyewear sales velocity.
The $400K-$700K investment isn't small, but the $130K-$400K owner earnings are real for those who execute. If you can't navigate telehealth rules or compete on value, stay out. If you can, this is a recession-resilient, high-margin play backed by an established group.
*Want the full breakdown on how to evaluate any franchise opportunity — including the questions most buyers miss? That's what I do at PULSE / CRO Syndicate. We don't sell dreams; we sell math. And this math checks out — if you do the work.*
*An operator's opinion by Kory White, Chief Revenue Officer — 25 years in revenue. More at PULSE · CRO Syndicate*
